LIVE SymposiumMonday, December 13, 20211:00 – 4:00 PM Eastern TimeRegister NowThere is an urgent need for quantitative biomarkers for neurological and psychiatric conditions to evaluate illness risk, facilitate diagnoses, and procedure drug treatment effectiveness. Due to the selective permeability of the blood-brain barrier, there are only trace amounts of brain-derived proteins in the plasma and cerebrospinal fluid, which makes it challenging to establish practical biomarker screening for brain conditions. Scientists look beyond the standard protein assays and integrate transcriptomics and practical imaging approaches to transform brain disorder diagnostics.In this virtual seminar, a skilled panel will go over how advances in single-cell sequencing, fluid-based RNA detection, and functional imaging speed up biomarker discovery to much better comprehend the brain in health and disease.Symposium program1:10 PM– Allison D. Ebert, PhD1:50 PM– Martina Absinta, PhD2:30 PM– Etay Hay, PhD3:10 – 4:00 PM – Open panel Q&A sessionSejal Davla from The Scientists Creative Services Team will be signed up with by the whole panel in an open question and answer session where speakers will address questions postured by the audience.Register NowMeet the speakersAllison D. Ebert, PhDAssociate ProfessorDepartment of Cell Biology, Neurobiology, and AnatomyDirector, Neuroscience Doctoral ProgramMedical College of Wisconsin, MilwaukeeMartina Absinta, PhDJunior FacultyVita-Salute San Raffaele UniversityMilan, ItalyEtay Hay, PhDIndependent ScientistKrembil Centre for NeuroinformaticsCentre for Addiction and Mental HealthAssistant ProfessorDepartments of Physiology and Psychiatry University of TorontoSymposium Sponsors
